1. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo
   Takanori Matsui et al, 2019, International Journal of Molecular Sciences CrossRef
2. Common cardiovascular medications in cancer therapeutics
   Christos Vaklavas et al, 2011, Pharmacology & Therapeutics CrossRef
3. The Intriguing Connection between Cholestasis and the Renin-Angiotensin System Dysregulation Induced by SARS-CoV-2 and/or the Vaccinal Spike Protein
   Ziad Fajloun et al, 2024, Infectious Disorders - Drug Targets CrossRef
4. Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms
   Yavuz Beyazit et al, 2011, Clinics and Research in Hepatology and Gastroenterology CrossRef
5. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor
   Audrey Clapéron et al, 2013, Hepatology CrossRef
6. An integrative study on the impact of highly differentially methylated genes on expression and cancer etiology
   Bugra Ozer et al, 2017, PLOS ONE CrossRef
7. Stellate Cells in the Tumor Microenvironment
   David Roife et al, 2020, Tumor Microenvironment CrossRef
8. Polypharmacology in Old Drug Rediscovery: Drug Repurposing
   Zhiguo Wang et al, 2022, Polypharmacology CrossRef
9. Molecular pathogenesis of biliary tract cancer
   Jason K. Sicklick et al, 2017, Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set CrossRef
10. Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions
    Maria Joana Catarata et al, 2020, Cancers CrossRef
11. Involvement of PSMD10, CDK4, and Tumor Suppressors in Development of Intrahepatic Cholangiocarcinoma of Syrian Golden Hamsters Induced by Clonorchis sinensis and N-Nitrosodimethylamine
    Md. Hafiz Uddin et al, 2015, PLOS Neglected Tropical Diseases CrossRef
12. Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of AGTR1+CAFs in intrahepatic cholangiocarcinoma
    Jian‐Hui Li et al, 2023, Clinical and Translational Medicine CrossRef
13. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma
    Alphonse E. Sirica, 2012, Nature Reviews Gastroenterology & Hepatology CrossRef
14. Angiotensin II/Angiotensin-(1–7)
    Patricia E. Gallagher et al, 2013, Handbook of Biologically Active Peptides CrossRef
15. Hematopoietic bone marrow renin-angiotensin system in health and disease
    Umit Yavuz Malkan et al, 2023, Angiotensin CrossRef
16. Repurposing of approved cardiovascular drugs
    Junichi Ishida et al, 2016, Journal of Translational Medicine CrossRef
17. Activation of the renin-angiotensin system stimulates biliary hyperplasia during cholestasis induced by extrahepatic bile duct ligation
    Syeda H. Afroze et al, 2015, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
18. The role of tumour microenvironment: a new vision for cholangiocarcinoma
    Ziyan Chen et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
19. Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives
    Hidehiro Tajima et al, 2017, Oncology Letters CrossRef
20. Central and peripheral nervous systems: master controllers in cancer metastasis
    Ming Shi et al, 2013, Cancer and Metastasis Reviews CrossRef
21. The role of the renin–angiotensin system in liver fibrosis
    M Kamruzzman Munshi et al, 2011, Experimental Biology and Medicine CrossRef
22. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
    Richard E. Kast et al, 2022, Cancers CrossRef
23. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma
    KOICHI OKAMOTO et al, 2012, International Journal of Oncology CrossRef
24. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription
    Wenjuan Rui et al, 2014, Journal of Ethnopharmacology CrossRef
25. The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
    Juanjuan Xu et al, 2017, Frontiers in Physiology CrossRef
26. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest
    Kyoko Oura et al, 2017, Oncology Reports CrossRef
27. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein
    Soichiro Saikawa et al, 2018, Cancer Letters CrossRef
28. The Angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer
    Mitsuyoshi Okazaki et al, 2014, Cancer Letters CrossRef
29. Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype
    Ming-Huei Chou et al, 2012, Biochemical Journal CrossRef
30. Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line
    ATSUSHI HIROSE et al, 2013, Oncology Letters CrossRef
31. Elastography for characterization of focal liver lesions: current evidence and future perspectives
    Carolina MARTELLETTI et al, 2021, Minerva Gastroenterology CrossRef
32. Elucidating the Association Between the Upregulation of Angiotensin Type 1-Receptors and the Development of Gastrointestinal Malignancies
    Mohammad-Hassan Arjmand, 2021, Journal of Gastrointestinal Cancer CrossRef
33. Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics
    Shipra Singhal et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
34. Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy
    Valerie Gunchick et al, 2023, The Oncologist CrossRef
35. Role of shear wave sono-elastography (SWE) in characterization of hepatic focal lesions
    Mahmoud Abdel-Latif et al, 2020, Egyptian Journal of Radiology and Nuclear Medicine CrossRef
36. Involvement of mast cell chymase in burn wound healing in hamsters
    XIANGLIN DONG et al, 2013, Experimental and Therapeutic Medicine CrossRef
37. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest
    Eri Samukawa et al, 2017, International Journal of Oncology CrossRef
38. Periostin in intrahepatic cholangiocarcinoma: Pathobiological insights and clinical implications
    Alphonse E. Sirica et al, 2014, Experimental and Molecular Pathology CrossRef
39. The ROS derived mitochondrial respirstion not from NADPH oxidase plays key role in Celastrol against angiotensin II-mediated HepG2 cell proliferation
    Xin Liu et al, 2016, Apoptosis CrossRef
40. Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound
    Aymeric Guibal et al, 2013, European Radiology CrossRef
41. Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study
    Xiao-Xu Zhu et al, 2023, BMC Cancer CrossRef
42. Association between ACE A240T polymorphism and cancer risk: a meta-analysis
    Yingjun Xiao et al, 2019, Journal of International Medical Research CrossRef
43. Neoadjuvant chemotherapy with gemcitabine‑based regimens improves the prognosis of node positive resectable pancreatic head cancer
    Hidehiro Tajima et al, 2019, Molecular and Clinical Oncology CrossRef
44. ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications
    Wook Jin, 2020, Journal of Clinical Medicine CrossRef
45. The use of Angiotensin II Receptor Antagonists to increase the Efficacy of Radiotherapy in Cancer Treatment
    Seyed Jalal Hosseinimehr, 2014, Future Oncology CrossRef
46. Immunohistochemical Profiling of Corneas With Fuchs Endothelial Corneal Dystrophy
    An-Katrien De Roo et al, 2017, Cornea CrossRef